US OptionsDetailed Quotes
AUR241220P12000
- 0.00
- 0.000.00%
15min DelayClose Dec 23 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest12.00Strike Price0.00Turnover0.00%IV-71.92%PremiumDec 20, 2024Expiry Date5.02Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Aurora Innovation Stock Discussion
Nov 5. Call, +57% so far.
Renovaro focuses on AI-driven healthcare innovation, particularly in early cancer detection and immunotherapy. Their flagship product, RenovaroCube, uses AI for diagnostics. The company has also acquired GEDi Cube and formed partnerships with institutions like Amsterdam UMC Cancer Center. Recent restructuring includes appointing David Weinstein as CEO .
2. $Rigetti Computing (RGTI.US)$Rigetti Co...
Using the Roman Sun Tzu Method™, here’s a breakdown of Aurora Innovation’s potential and strategic positioning in the market.
Applying the Roman Sun Tzu Method™ to AUR
Strategic Insights:
1. Momentum and Positioning:
Aurora Innovation aligns with the Roman Sun Tzu Method’s focus on disruptive technologies like autonomous trucking and AI. Much like Sun Tzu’s advice to seize pivotal terrain, AUR’s leadership in autonomous tru...
Opened a very speculative position in $Tilray Brands (TLRY.US)$ (calls and LEAPS calls - IV is high, so not much but a bit of fun.
this stock is at support, and ready to plug profits into.. Just received great news, all profit, no debt, beat earnings,no shorties, just needs volume and many brothers and sisters are squashed down and been squashed down for a min.. All it need now is this kind of volume.. cmon ✈️🙏🙏🙏
I'm thankful for ALL Im blessed with💓 🫁 🏠 💸
🙏🎶🥁🕺🎶💃🌹🎶🙏
this gonna vibrate it back to you
🎶🎶🎶🎶🎶🎶🎶🎶🎶🎶🎶🎶🎶🎶
Once this sell-off is done, time to jump back in.
The delay in launch (as stated in earnings call) was due to factors outside their control. Paccar supply issues prevented the timeline for regulations and testing being met.
To see why this isn't a bad thing, refer to "contra R&D expense"
Some assistance for the unfamiliar:
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
as a high reward with decreasing risks play, for short term trades, and, if they show that they can scale, a longterm hold.
It is part of my speculation basket that includes companies like $AST SpaceMobile (ASTS.US)$
and $Aurora Innovation (AUR.US)$
all of which I trade in shorterm options, longer dated contracts and warrants, while also investing in shares, LEAPS calls and synthetic longs.
I’ve traded out of December AUR calls these p...
No comment yet